Tuesday, 29 March 2011

Natalizumab can lead to sustained improvements in disability

Why can't patients improve on disease modifying therapies?

Please see Phillips et al. Mult Scler. 2011 Mar 18.

No comments:

Post a Comment

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.